From: Identification and validation of m5c-related lncRNA risk model for ovarian cancer
Characteristics | Unknow |  | Total set(n = 375) | Testing set (n = 187) | Training set (n = 188) | P |
---|---|---|---|---|---|---|
Age,n(%) | 0 | age ≤ 65 | 257(68.533) | 122(65.241) | 135(71.809) | 0.171 |
 | age > 65 | 118(31.467) | 65(34.759) | 53(28.191) |  | |
Status,n(%) | 47 | Tumor free | 84(25.610) | 36(22.222) | 48(28.916) | 0.165 |
 | With tumor | 244(74.390) | 126(77.778) | 118(71.084) |  | |
Vascular invasion,n(%) | 272 | No | 40(38.835) | 17(37.778) | 23(39.655) | 0.846 |
 | Yes | 63(61.165) | 28(62.222) | 35(60.345) |  | |
Lymph nodes invasion,n(%) | 228 | No | 47(31.973) | 20(31.746) | 27(32.143) | 0.959 |
 | Yes | 100(68.027) | 43(68.254) | 57(67.857) |  | |
Grade,n(%) | 1 | G1 | 1(0.267) | 0(0.000) | 1(0.535) | 0.935 |
 | G2 | 42(11.230) | 22(11.765) | 20(10.695) |  | |
 | G3 | 321(85.829) | 160(85.561) | 161(86.096) |  | |
 | G4 | 1(0.267) | 0(0.000) | 1(0.535) |  | |
 | GX | 9(2.406) | 5(2.674) | 4(2.139) |  | |
Stage,n(%) | 3 | Stage I | 1(0.269) | 1(0.535) | 0(0.000) | 0.716 |
 | Stage II | 21(5.645) | 12(6.417) | 9(4.865) |  | |
 | Stage III | 292(78.495) | 147(78.610) | 145(78.378) |  | |
 | Stage IV | 58(15.591) | 27(14.439) | 31(16.757) |  | |
Dimension, mean(± SD) | 14 | (cm) | 0.905 ± 0.394 | 0.876 ± 0.327 | 0.934 ± 0.450 | 0.158 |